BrandWikiReturn

Sinopharm Group

Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.

Its H shares were listed on the Hong Kong Stock Exchange in 2009,[2] with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.

Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list.[3]

COVID-19 Vaccine development

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV,[4] the Sinopharm COVID-19 vaccine,[5] or BIBP vaccine,[5][6][7] is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants.[8] The BIBP vaccine shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19.[9]

Peer-reviewed results published in JAMA of Phase III trials in United Arab Emirates and Bahrain showed that the BIBP vaccine is 78.1% effective against symptomatic cases and 100% against severe cases (21 cases in vaccinated group vs. 95 cases in placebo group).[10] In December 2020, the UAE previously announced interim results showing 86% efficacy.[11] While mRNA vaccines showed higher efficacy of over 90%, those present distribution challenges for some nations as they require deep-freeze facilities and trucks. BIBP-CorV could be transported and stored at normal refrigerated temperatures.[12]

The BIBP vaccine is being used in vaccination campaigns by certain countries in Asia,[13][14][15] Africa,[16][17][18] South America,[19][20][21] and Europe.[22][23][24] Sinopharm was expected to produce one billion doses of the BIBP vaccine in 2021.[25] On 7 May 2021, the World Health Organization approved the vaccine for use in COVAX.[14][26]

See also

  • Pharmaceutical industry in China

External links

References

  1. 2015 Annual Report Sinopharm Group, Hong Kong Stock Exchange, 25 April 2016, retrieved 22 November 2016^
  2. China's Sinopharm gets OK for $1 bln HK IPO Reuters, 2009-07-29, retrieved 2020-11-14^
  3. Sinopharm Group Forbes, retrieved 2020-11-14^
  4. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial The Lancet. Infectious Diseases, January 2021^
  5. The Sinopharm COVID-19 vaccine: What you need to know World Health Organization, 10 May 2021, retrieved 5 July 2021^
  6. Coronavirus: Vietnam approves Sinopharm's vaccine, but will people take it? South China Morning Post, 5 June 2021, retrieved 5 July 2021^
  7. What we now know about the efficacy of China's Covid-19 vaccines Quartz, 16 June 2021, retrieved 5 July 2021^
  8. China Sinopharm's coronavirus vaccine taken by about a million people in emergency use Reuters, 2020-11-19, retrieved 2020-12-09^
  9. Jonathan Corum, Carl Zimmer. How the Sinopharm Vaccine Works The New York Times, 2021-04-26, retrieved 2021-04-29^
  10. Nawal Al Kaabi, Yuntao Zhang, Shengli Xia, Yunkai Yang, Manaf M. Al Qahtani, Najiba Abdulrazzaq, Majed Al Nusair, Mohamed Hassany. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial JAMA, May 26, 2021^
  11. UAE: Ministry of Health announces 86 per cent vaccine efficacy gulfnews.com, 9 December 2020, retrieved 2020-12-13^
  12. China State-Backed Covid Vaccine Has 86% Efficacy, UAE Says Bloomberg.com, 2020-12-09, retrieved 2020-12-09^
  13. China gives its first COVID-19 vaccine approval to Sinopharm Reuters, 2020-12-31, retrieved 2020-12-31^
  14. Natasha Turak. The UAE is on track to have half its population vaccinated by the end of March CNBC, 2021-01-18, retrieved 2021-01-21^
  15. Dawn.com. PM Imran kicks off Pakistan's Covid-19 vaccination drive DAWN.COM, 2021-02-02, retrieved 2021-02-03^
  16. Sisi says Egypt to begin COVID-19 vaccinations on Sunday Reuters, 2021-01-24, retrieved 2021-01-24^
  17. Toms Dumpis. Morocco Receives Half a Million Doses of Chinese Sinopharm Vaccine Morocco World News, 2021-01-27, retrieved 2021-01-28^
  18. Zimbabwe starts administering China's Sinopharm vaccines thestar.com, 2021-02-18, retrieved 2021-02-20^
  19. Argentina autoriza la vacuna china Sinopharm para mayores de 60 años El Comercio, 25 March 2021, retrieved 2021-03-26^
  20. Marco Aquino. 'The best shield': Peru launches inoculation drive with Sinopharm vaccine Reuters, 2021-02-10, retrieved 2021-02-10^
  21. Bolivia begins inoculation with Sinopharm jabs www.thestar.com.my, retrieved 2021-02-28^
  22. Serbia Becomes First European Nation To Use China's Sinopharm Vaccine Radio Free Europe/Radio Liberty, 20 January 2021, retrieved 2021-01-21^
  23. Hungary first EU nation to use China's Sinopharm vaccine against COVID euronews, 2021-02-24, retrieved 2021-02-26^
  24. Belarus begins COVID-19 vaccinations with Chinese shots eng.belta.by, 2021-03-15, retrieved 2021-03-16^
  25. Which companies will likely produce the most COVID-19 vaccine in 2021? Pharmaceutical Processing World, 2021-02-05, retrieved 2021-02-28^
  26. Adam Taylor. WHO grants emergency use authorization for Chinese-made Sinopharm coronavirus vaccine The Washington Post, 7 May 2021, retrieved 7 May 2021^